Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.97 USD | +1.27% | -10.70% | +627.09% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 243M | Sales 2025 * | 274M | Capitalization | 516M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -46M | EV / Sales 2024 * | 2.12 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
-6.87
x | P/E ratio 2025 * |
-12.6
x | Employees | 1,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on GeneDx Holdings Corp.
1 day | -1.35% | ||
1 week | -17.90% | ||
Current month | +15.52% | ||
1 month | +64.33% | ||
3 months | +150.25% | ||
6 months | +1,298.58% | ||
Current year | +617.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-04-28 | |
Kevin Feeley
DFI | Director of Finance/CFO | 43 | - |
Paul Kruszka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 74 | 21-07-21 |
Director/Board Member | 68 | 22-04-30 | |
Keith Meister
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 20 | +1.39% | 32 389 |
24-05-23 | 19.72 | -1.35% | 238,125 |
24-05-22 | 19.99 | -3.66% | 210,867 |
24-05-21 | 20.75 | -4.64% | 236,711 |
24-05-20 | 21.76 | -2.81% | 241,174 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+617.09% | 516M | |
-23.07% | 8.1B | |
+2.11% | 2.57B | |
-7.71% | 2.49B | |
-40.47% | 2.39B | |
-14.15% | 1.77B | |
-20.84% | 1.53B | |
-42.17% | 1.18B | |
+16.01% | 1.2B | |
+14.98% | 956M |
- Stock Market
- Equities
- WGS Stock